Barry Callebaut Balance Sheet Health
Financial Health criteria checks 3/6
Barry Callebaut has a total shareholder equity of CHF2.8B and total debt of CHF4.5B, which brings its debt-to-equity ratio to 157.8%. Its total assets and total liabilities are CHF15.2B and CHF12.3B respectively. Barry Callebaut's EBIT is CHF904.4M making its interest coverage ratio 4.6. It has cash and short-term investments of CHF993.6M.
Key information
157.8%
Debt to equity ratio
CHF 4.48b
Debt
Interest coverage ratio | 4.6x |
Cash | CHF 993.63m |
Equity | CHF 2.84b |
Total liabilities | CHF 12.32b |
Total assets | CHF 15.16b |
Recent financial health updates
Does Barry Callebaut (VTX:BARN) Have A Healthy Balance Sheet?
Aug 25Does Barry Callebaut (VTX:BARN) Have A Healthy Balance Sheet?
May 21Recent updates
We Think That There Are More Issues For Barry Callebaut (VTX:BARN) Than Just Sluggish Earnings
Nov 13Does Barry Callebaut (VTX:BARN) Have A Healthy Balance Sheet?
Aug 25Barry Callebaut AG's (VTX:BARN) Popularity With Investors Is Clear
Jun 27Calculating The Intrinsic Value Of Barry Callebaut AG (VTX:BARN)
Jun 08Does Barry Callebaut (VTX:BARN) Have A Healthy Balance Sheet?
May 21Barry Callebaut's (VTX:BARN) Soft Earnings Are Actually Better Than They Appear
Apr 18Barry Callebaut's (VTX:BARN) Returns Have Hit A Wall
Apr 04Fewer Investors Than Expected Jumping On Barry Callebaut AG (VTX:BARN)
Feb 21Returns On Capital At Barry Callebaut (VTX:BARN) Have Hit The Brakes
Dec 28Financial Position Analysis
Short Term Liabilities: BARN's short term assets (CHF12.2B) exceed its short term liabilities (CHF8.9B).
Long Term Liabilities: BARN's short term assets (CHF12.2B) exceed its long term liabilities (CHF3.4B).
Debt to Equity History and Analysis
Debt Level: BARN's net debt to equity ratio (122.8%) is considered high.
Reducing Debt: BARN's debt to equity ratio has increased from 77.9% to 157.8% over the past 5 years.
Debt Coverage: BARN's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: BARN's interest payments on its debt are well covered by EBIT (4.6x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/19 01:03 |
End of Day Share Price | 2024/12/19 00:00 |
Earnings | 2024/08/31 |
Annual Earnings | 2024/08/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Barry Callebaut AG is covered by 30 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Andreas von Arx | Baader Helvea Equity Research |
Volker Bosse | Baader Helvea Equity Research |
Laura Pfeifer-Rossi | Bank am Bellevue |